Chemotherapy in elderly small-cell lung cancer patients: Yes we can, but should we do it?

Annals of Oncology

Volumn 22, Issue 4, 2011, Pages 821-826

  Janssen Heijnen, M L G ^a,b   Maas, H A A M ^c   van de Schans, S A M ^a   Coebergh, J W W ^a,b   Groen, H J M ^d  

^a Erasmus University Rotterdam and Eindhoven Cancer Registry   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c TweeSteden Hospital   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Elderly; Population based; Small cell lung cancer; Toxicity; Treatment tolerance

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

AGE; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIOTOXICITY; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG FATALITY; ELDERLY CARE; FEMALE; GERIATRIC PATIENT; HUMAN; INFECTION; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; SOCIAL SUPPORT; TREATMENT REFUSAL;

EID: 79953314268     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq448     Document Type: Article

References (29)

1. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003; 41: 245-258.
2. Kurup A, Hanna NH. Treatment of small cell lung cancer. Crit Rev Oncol Hematol 2004; 52: 117-126.
3. Pallis AG, Shepherd FA, Lacombe D, Gridelli C. Treatment of small-cell lung cancer in elderly patients. Cancer 2010; 116: 1192-1200.
4. Slotman B, Faivre-Finn C, Kramer G et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007; 357: 664-672.
5. Janssen-Heijnen ML, Lemmens VE, van den Borne BE et al. Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: a population-based study in the Netherlands. Crit Rev Oncol Hematol 2007; 62: 172-178.
6. Hutchins LF, Unger JM, Crowley JJ et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061-2067.
7. Piccirillo JF, Tierney RM, Costas I et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 2441-2447.
8. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events (CTCAE), Version 3.0. National Institutes of Health, National Cancer Institute, Bethesda, MD 2003.
9. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005; 366: 1385-1396.
10. Singh S, Parulekar W, Murray N et al. Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol 2005; 23: 850-856.
11. Wheatley-Price P, Ma C, Ashcroft LF et al. The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit. Ann Oncol 2009; 21: 232-237.
12. Jara C, Gomez-Aldaravi JL, Tirado R et al. Small-cell lung cancer in the elderly-is age of patient a relevant factor? Acta Oncol 1999; 38: 781-786.
13. Ludbrook JJ, Truong PT, MacNeil MV et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 2003; 55: 1321-1330.
14. Deppermann KM. Influence of age and comorbidities on the chemotherapeutic management of lung cancer. Lung Cancer 2001; 33 (Suppl 1): S115-S120.
15. Weinmann M, Jeremic B, Bamberg M, Bokemeyer C. Treatment of lung cancer in elderly part II: small cell lung cancer. Lung Cancer 2003; 40: 1-16.
16. Vinod SK, Sidhom MA, Gabriel GS et al. Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol 2010; 5: 1025-1032.
17. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998; 317: 771-775.
18. Weeks JC, Cook EF, O'Day SJ et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998; 279: 1709-1714.
19. Quoix E, Breton JL, Daniel C et al. Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study. Ann Oncol 2001; 12: 957-962.
20. Gridelli C, De Vivo R, Monfardini S. Management of small-cell lung cancer in the elderly. Crit Rev Oncol Hematol 2002; 41: 79-88.
21. De Ruysscher D, Botterweck A, Dirx M et al. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol 2009; 20: 98-102.
22. Siu LL, Shepherd FA, Murray N et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996; 14: 821-828.
23. Yuen AR, Zou G, Turrisi AT et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 2000; 89: 1953-1960.
24. Schild SE, Stella PJ, Brooks BJ et al. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer 2005; 103: 2349-2354.
25. de Jong WK, Groen HJ, Koolen MG et al. Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer. Eur J Cancer 2007; 43: 2345-2350.
26. Demedts IK, Vermaelen KY, van Meerbeeck JP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J 2010; 35: 202-215.
27. Ardizzoni A, Favaretto A, Boni L et al. Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis-a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study. J Clin Oncol 2005; 23: 569-575.
28. Maas HA, Janssen-Heijnen ML, Olde Rikkert MG, Machteld Wymenga AN. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 2007; 43: 2161-2169.
29. Rodin MB, Mohile SG. A practical approach to geriatric assessment in oncology. J Clin Oncol 2007; 25: 1936-1944.